Product details

Share this page:
Please find below the full details of the product you clicked a link to view.
Published by:
INSEAD (2014)
Version:
05.2016
Revision date:
06-Jun-2016
Length:
27 pages
Data source:
Published sources

Abstract

Mindray Medical International Limited, China's second largest medical device manufacturer, had global sales of 2.23 billion RMB in 2007. Since 2002, it had launched between seven and nine new products every year across four product lines: Patient Monitoring & Life Support products, the In-Vitro Diagnostic Products, Medical Imaging Systems and Veterinary. In 2006, Mindray's American depositary shares (ADS) were listed on the New York Stock Exchange. By the end of 2007, Mindray had sold medical devices to over 37,500 hospitals and clinics in China. It had 12 international offices and its products were sold in more than 140 countries. However, the company's US performance had not lived up to expectations. Founder and chairman, Hang Xu, had been approached by a leading investment bank to discuss the potential acquisition of Datascope, a mid-sized American producer of medical devices for the global marketplace. What should he do?

Topics

Marketing; Global strategy; Branding; China; Emerging markets; EMNC; Health care; Medical diagnostics
Other setting(s):
2007

Access this item

casecent.re/p/120042
View our pricing guide
or to see prices.

Reviews & usage